polysaccharide-K: Clinical Trials

3 trials of polysaccharide-K, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated, 1 unknown. 3 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Terminated 1, Unknown 1
Phase 11Completed 1
Phase 31Terminated 1

Follow polysaccharide-K: new trials by email Literature Review of polysaccharide-K trials Research Report on polysaccharide-K

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vaccine Therapy With or Without Polysaccharide-K in Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody Therapy
HER-2/neu Intracellular Domain Protein, Laboratory Biomarker Analysis, Pertuzumab - HER2/Neu Positive, Recurrent Breast Carcinoma
Phase 1 / Phase 2CompletedUniversity of Washington312014-02-052023-04-18
Feasibility Study of CDDP + CPT-11 + PSK for Extensive-Stage Disease (ED) Small Cell Lung Cancer
Irinotecan hydrochloride, Cisplatin, Krestin - Small Cell Lung Cancer
Phase 2UnknownUniversity of Toyama452007-11-012008-09-03
Phase II Study of TS-1 Therapy and TS-1+PSK Therapy Against Advanced Gastric Carcinoma
Tegafur/gimeracil/oteracil potassium (S-1), Krestin (PSK), Tegafur/gimeracil/oteracil potassium (S-1) - Gastric Cancer
Phase 2 / Phase 3TerminatedEastern Network of Cancer Immunological Therapy, Japan132006-10-012009-01-23

Conditions studied

Breast Neoplasms (1)  ·  Small Cell Lung Carcinoma (1)  ·  Stomach Neoplasms (1)

Sponsors

Eastern Network of Cancer Immunological Therapy, Japan (1)  ·  University of Toyama (1)  ·  University of Washington (1)

Countries

Japan (2)  ·  United States (1)

Top investigators

Hideaki Tahara, MD (1)  ·  Lupe Salazar (1)  ·  Tatsuhiko Kashii, MD, PhD (1)

NIH funding

P30CA015704 (1), U19AT006028 (1)